Lunes, 19 Noviembre, 2018

Cancer claims about Johnson & Johnson's baby powder net woman $110M

The logo of Uber is seen on an iPad during a news conference to announce Uber resumes ride-hailing service in Taipei Taiwan The logo of Uber is seen on an iPad during a news conference to announce Uber resumes ride-hailing service in Taipei Taiwan
Cris De Lacerda | 06 May, 2017, 08:37

However, it hasn't stopped the courts from awarding damages to numerous women.

The attorney's plea followed 17 days of testimony in the case of Lois Slemp, a 61-year-old woman from Virginia who suffers from Stage III (c) ovarian cancer.

Much research has found no link or a weak one between ovarian cancer and using baby powder for feminine hygiene, and most major health groups have declared talc harmless.

In May 2016, another Missouri jury awarded US$55 million to a woman who said J&J's talc-powder products caused her to develop ovarian cancer.

Johnson & Johnson on Thursday was ordered by a Missouri jury to pay over Dollars 110 million to a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene.

In a statement, J&J said that it sympathized with women impacted by ovarian cancer but planned to appeal."We are preparing for additional trials this year and we continue to defend the safety of Johnson's Baby Powder", J&J said.The verdict came after J&J secured its first trial win in the Missouri litigation, when a jury in March sided with the company in a lawsuit by a Tennessee woman who said she developed cancer after using Baby Powder. Yet the company took no action to warn consumers and even engaged in an intense lobbying campaign to ensure regulators did not declare talc a carcinogen, according to Slemp's lawsuit. During his closing statements, Slemp's attorney called Johnson & Johnson's alleged conduct "reprehensible" and urged jurors to punish the company.

Obstetrician and gynaecologist Elisa Koh at Mount Elizabeth Novena Specialist Centre said while the entry of the powder through the genital tract could be an issue, using it on the chest or face is unlikely to cause problems. Not all of the trials have found for the plaintiff.

It awarded punitive damages of $142 million against J&J and a unit and $670,000 against Imerys.

That verdict broke a three-trial winning streak by plaintiffs that began with a verdict in February 2016 in which a jury ordered J&J to pay $72 million to the family of a woman who died from ovarian cancer.